Related Experiment Video
Updated: Aug 4, 2026
07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Metachromatic leukodystrophy: consequences of sulphatide accumulation
V Gieselmann1, S Franken, D Klein
1Institut für Physiologische Chemie, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. gieselmann@institut.physiochem.uni-bonn.de
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|March 3, 2004
Summary
Metachromatic leukodystrophy, a genetic disorder, causes progressive demyelination due to sulphatide accumulation. An arylsulphatase A knock-out mouse model reveals key cellular and histopathological changes.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Metachromatic leukodystrophy (MLD) is a lysosomal lipid storage disorder.
- It results from mutations in the arylsulphatase A gene, impairing sphingolipid (sulphatide) degradation.
- Sulphatide accumulates, particularly in the nervous system's myelin, leading to demyelination.
Purpose of the Study:
- To review insights into MLD pathogenesis.
- To analyze data from an arylsulphatase A knock-out mouse model.
Main Methods:
- Review of existing data.
- Utilizing an arylsulphatase A knock-out mouse model of MLD.
Main Results:
- Sulphatide accumulation affects oligodendrocytes, neurons, and glial cells (astrogliosis, microglial activation).
- Lysosomal storage alters myelin composition and associated proteins.
- The mouse model recapitulates key pathological features of MLD.
Conclusions:
- The arylsulphatase A knock-out mouse model is valuable for studying MLD.
- This model provides insights into the histopathological and cellular consequences of sulphatide storage in MLD.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...